Log In
BCIQ
Print this Print this
 

EYP001

  Manage Alerts
Collapse Summary General Information
Company Poxel S.A.
DescriptionFarnesoid X receptor (FXR; NR1H4) agonist
Molecular Target Farnesoid X receptor (FXR) (NR1H4)
Mechanism of ActionFarnesoid X receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat Hepatitis B virus (HBV) infection
Regulatory Designation
PartnerEnyo Pharma S.A.S.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today